BROOKE HARBOR HEALTH SYSTEM INTRANET ALL TRAINING SYSTEMS OPERATIONAL
BH

Brooke Harbor Health System

PMHNP Clinical Learning Environment

TRAINING ENVIRONMENTFictional educational health system · No real patient data
Updated July 31, 2026

PMHNP Clinical Toolbox

Treatment Planning

Build a plan that follows from the assessment, reflects the patient’s priorities and context, addresses safety, and makes the reasoning, monitoring, and next steps visible.

Before selecting treatment

Confirm that the plan rests on the right foundation

01

Diagnostic confidence

Name the working diagnosis, important alternatives, and what remains uncertain.

02

Safety & level of care

Address acute risk, medical instability, withdrawal, impaired capacity, and the safest treatment setting first.

03

Contributors

Account for medical conditions, medications, substances, sleep, trauma, development, and psychosocial context.

04

Treatment history

Clarify prior benefit, adverse effects, adherence, adequacy of trials, access barriers, and patient preferences.

Whole-plan framework

Six domains of a complete plan

Not every encounter requires a new action in every domain, but each domain should be considered and clinically important omissions should be explained.

01

Safety & setting

State the level of care, immediate precautions, crisis plan, means-safety work, and reassessment interval when relevant.

02

Goals & measurement

Define patient-centered targets for symptoms, function, quality of life, and safety. Identify how progress will be measured.

03

Psychotherapy

Match the modality, intensity, format, and referral to the diagnosis, patient goals, readiness, age, culture, and access.

04

Medication strategy

Document the indication, expected benefit, alternatives, risks, monitoring, education, and follow-up for each decision.

05

Health & supportive care

Address sleep, nutrition, movement, substance use, medical care, social needs, and evidence-informed adjunctive approaches.

06

Coordination & follow-up

Identify collaborators, referrals, consent needs, contingency plans, responsibility for monitoring, and timing of follow-up.

Medication decisions

Make each choice traceable

“Continue,” “start,” “increase,” or “stop” is not enough. Connect every medication decision to a target, evidence, patient-specific benefit–risk reasoning, monitoring, education, and a follow-up decision point.

Indication

What specific target or condition is this medication intended to treat?

Evidence

Does current guidance support this option for this diagnosis, phase, age, and clinical context?

Patient fit

How do comorbidities, reproductive considerations, organ function, prior response, family history, and preferences affect the choice?

Total burden

What interactions, duplications, adherence demands, anticholinergic load, metabolic effects, sedation, activation, or misuse risks matter?

Monitoring

What baseline data, ongoing assessment, rating scales, laboratory testing, vital signs, or physical examination are required?

Feasibility

Can the patient obtain, understand, afford, store, and take the treatment as planned?

Exit plan

When will benefit and harm be reassessed, and what would prompt titration, switching, tapering, consultation, or a higher level of care?

Shared decision-making

Translate options into a decision the patient can use

ExplainDiagnosis, uncertainty, reasonable options, expected time course, benefits, common and serious harms, and alternatives.
ElicitGoals, concerns, prior experiences, culture, supports, treatment burden, cost, access, and preferences.
AgreeThe selected plan, what the patient will do, what the clinician will do, monitoring, follow-up, and contingency steps.

Authoritative starting points

Guidelines, labeling, and evidence resources

Use the most current condition-specific guideline and verify medication information against current labeling and safety updates. Apply each guideline through patient-specific clinical judgment.

American Psychiatric Association

APA Clinical Practice Guidelines

Evidence-based psychiatric treatment guidelines, including schizophrenia and eating disorders.

Open resource
VA/DoD

VA/DoD Mental Health Guidelines

Current guidance for depression, bipolar disorder, psychosis, PTSD, suicide risk, substance use, and related conditions.

Open resource
NICE

NICE Mental Health Guidance

Condition-specific recommendations spanning medication, psychological treatment, service delivery, and follow-up.

Open resource
National Library of Medicine

DailyMed

Search current labeling submitted to the FDA for indications, dosing, contraindications, warnings, interactions, and patient information.

Open resource
U.S. Food & Drug Administration

FDA Drug Safety

Review current safety communications, labeling changes, alerts, recalls, and medication availability information.

Open resource
National Library of Medicine

LactMed

Peer-reviewed information about medications and other exposures during lactation, including reported infant effects and alternatives.

Open resource
SAMHSA

SAMHSA Evidence-Based Practices

Practice resources for mental health and substance-use treatment, integrated care, recovery, and service delivery.

Open resource